Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: The impact of persistent oropharyngeal carriage

Journal of Pediatrics

Volumn 137, Issue 3, 2000, Pages 313-320

  Singleton, Rosalyn ^a,b,c   Bulkow, Lisa R ^a,b,c   Levine, Orin S ^a,b,c   Butler, Jay C ^a,b,c   Hennessy, Thomas W ^a,b,c   Parkinson, Alan ^a,b,c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; ETHNIC GROUP; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT DISEASE; INFECTION RISK; MAJOR CLINICAL STUDY; OROPHARYNX; POPULATION RISK; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

EID: 0033827475     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.107843     Document Type: Article

References (29)

1. Haemophilus influenzae disease in Alaskan Eskimos: Characteristics of a population with an unusual incidence of invasive disease
2. Invasive Haemophilus influenzae type b disease in Alaska: Background epidemiology for a vaccine efficacy trial
3. Epidemiology of Haemophilus influenzae type b infections in the United States
4. Haemophilus influenzae vaccines
5. Pharyngeal carriage and acquisition of anticapsular antibody to Haemophilus influenzae type b in a high-risk population in southwestern Alaska
6. Nasopharyngeal carriage of Haemophilus influenzae type b
7. Factors affecting pharyngeal Haemophilus influenzae type b colonization rates in children
8. Re-emergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska
9. Use of antiserum agar for detection of Haemophilus influenzae type b in the pharynx
10. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants
11. Decline of Haemophilus influenzae type b disease in a region of high risk: Impact of passive and active immunization
12. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants
13. Comparative trial in infants of four conjugate Haemaphilus influenzae type b vaccines
14. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate Vaccines in infants
15. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer membrane protein complex
16. Progress toward eliminating Haemophilus influenzae type b disease among infants and children - United States 1987-1997
17. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b
18. Carriage of Haemaphilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines
19. Decreased Haemophilus influenzae colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine
20. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine
21. Decline of childhood Haemaphilus influenzae type b (Hib) disease in the Hib vaccine era
22. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs
23. Anticapsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines
24. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children
25. National, state, and urban area vaccination coverage levels among Children aged 18-35 Months - United States, July 1996- June 1997
26. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status
27. Enhanced immunogenicity of a sequential Haemophilus influenzae type b vaccine schedule in Alaska Native infants
28. Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b vaccines in the primary series: Evaluation of a two-dose mixed regimen
29. Interchangeability of Haemophilus influenzae type b vaccines in the primary series; evaluation of a two-dose mixed regimen